Daniel Alain, Inc.
Daniel Alain, Inc.
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia | Chemotherapy Induced Alopecia; Chemotherapy Side Effects | Recruiting | Phase 1 / Phase 2 | 2026-08-21 | NCT07397325 | |
| Pharmacokinetic Study of DA-020 | Chemotherapy Induced Alopecia; Chemotherapy Side Effects | Not yet recruiting | Early phase 1 | 2026-04-13 | NCT07402330 | |
| Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth | Alopecia, Male Pattern, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, androgenetic alopecia, disorder of pilosebaceous unit, hypotrichosis, skin disorder, telogen effluvium | Not yet recruiting | Phase 2 / Phase 3 | 2026-04-13 | NCT06648850 | |
| Pharmacokinetic Study of Topical Phenylephrine | Chemotherapy Induced Alopecia; Chemotherapy Side Effects | Recruiting | Early phase 1 | 2025-10-03 | NCT07033845 | |
| Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia | Chemotherapy Induced Alopecia; Chemotherapy Side Effects | Not yet recruiting | Phase 3 | 2025-05-23 | NCT06762548 | |
| Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss | Alopecia, Male Pattern, Female Pattern Baldness, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, androgenetic alopecia, disorder of pilosebaceous unit, hypotrichosis, skin disorder | Not yet recruiting | Phase 3 | 2024-12-19 | NCT06501924 |